CL2020002715A1 - Composiciones y métodos para tratar la endometriosis - Google Patents

Composiciones y métodos para tratar la endometriosis

Info

Publication number
CL2020002715A1
CL2020002715A1 CL2020002715A CL2020002715A CL2020002715A1 CL 2020002715 A1 CL2020002715 A1 CL 2020002715A1 CL 2020002715 A CL2020002715 A CL 2020002715A CL 2020002715 A CL2020002715 A CL 2020002715A CL 2020002715 A1 CL2020002715 A1 CL 2020002715A1
Authority
CL
Chile
Prior art keywords
methods
compositions
treating endometriosis
endometriosis
diagnosis
Prior art date
Application number
CL2020002715A
Other languages
English (en)
Inventor
Kirma Nameer
Nicholson Bruce
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of CL2020002715A1 publication Critical patent/CL2020002715A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56966—Animal cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/36—Gynecology or obstetrics
    • G01N2800/364—Endometriosis, i.e. non-malignant disorder in which functioning endometrial tissue is present outside the uterine cavity

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • Urology & Nephrology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)

Abstract

En la presente se describen los métodos para la detección y el diagnóstico de la endometriosis. Más específicamente, se proporcionan métodos de análisis de la expresión de una sola célula sensible para detectar los patrones de expresión génica en poblaciones celulares obtenidos de células endometriales.
CL2020002715A 2018-04-20 2020-10-20 Composiciones y métodos para tratar la endometriosis CL2020002715A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201862660641P 2018-04-20 2018-04-20

Publications (1)

Publication Number Publication Date
CL2020002715A1 true CL2020002715A1 (es) 2021-06-11

Family

ID=68240339

Family Applications (3)

Application Number Title Priority Date Filing Date
CL2020002715A CL2020002715A1 (es) 2018-04-20 2020-10-20 Composiciones y métodos para tratar la endometriosis
CL2023000509A CL2023000509A1 (es) 2018-04-20 2023-02-20 Composiciones y métodos para tratar la endometriosis
CL2024000180A CL2024000180A1 (es) 2018-04-20 2024-01-19 Composiciones y métodos para tratar la endometriosis.

Family Applications After (2)

Application Number Title Priority Date Filing Date
CL2023000509A CL2023000509A1 (es) 2018-04-20 2023-02-20 Composiciones y métodos para tratar la endometriosis
CL2024000180A CL2024000180A1 (es) 2018-04-20 2024-01-19 Composiciones y métodos para tratar la endometriosis.

Country Status (11)

Country Link
US (1) US20210238683A1 (es)
EP (1) EP3781945A4 (es)
JP (2) JP2021521803A (es)
KR (1) KR102897619B1 (es)
CN (1) CN112470002A (es)
AU (1) AU2019255402B2 (es)
BR (1) BR112020021372A2 (es)
CA (1) CA3097421A1 (es)
CL (3) CL2020002715A1 (es)
MX (1) MX2020011119A (es)
WO (1) WO2019204803A1 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114788836A (zh) * 2021-09-09 2022-07-26 青岛大学附属医院 脐血干细胞分泌物在加快子宫内膜细胞的细胞周期中的应用
WO2023107375A1 (en) * 2021-12-07 2023-06-15 The Feinstein Institutes For Medical Research Improved methods for detecting and treating endometriosis
KR102677786B1 (ko) * 2021-12-13 2024-06-25 (주)비엠에스 Nrg1 및 smad7 유전자 발현 수준을 이용한 자궁내막증 진단을 위한 정보 제공 방법 및 이를 위한 조성물

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1290218B8 (en) * 2000-02-25 2007-10-03 Siemens Medical Solutions Diagnostics Endometriosis-related markers and uses thereof
ATE397098T1 (de) * 2002-08-30 2008-06-15 Oncotherapy Science Inc Verfahren zur diagnostik von eierstock endometriose
WO2006091254A1 (en) * 2005-02-18 2006-08-31 The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Identification of molecular diagnostic markers for endometriosis in blood lymphocytes
CN104350374B (zh) * 2012-02-29 2018-04-27 富鲁达公司 用于使用微流体的多个单细胞捕获和处理的方法、系统和设备
US10927412B2 (en) * 2013-10-01 2021-02-23 The Regents Of The University Of California Endometriosis classifier
WO2016065242A1 (en) * 2014-10-24 2016-04-28 The Trustees Of Columbia University In The City Of New York Microfluidic qrt-pcr analysis of single cells
MX379073B (es) * 2015-04-13 2025-03-10 Univ Johns Hopkins Plataforma multiplexada de flujo continuo a base de gotas para deteccion genetica de alto rendimiento.
CN105886659A (zh) * 2016-06-29 2016-08-24 北京泱深生物信息技术有限公司 Dstn基因及其表达产物作为子宫内膜癌的诊治靶标
CN106119358B (zh) * 2016-06-29 2019-08-13 北京泱深生物信息技术有限公司 子宫内膜癌生物标志物的诊治产品
CN106119357B (zh) * 2016-06-29 2019-09-10 北京泱深生物信息技术有限公司 Tns11在制备诊治子宫内膜癌产品中的应用

Also Published As

Publication number Publication date
US20210238683A1 (en) 2021-08-05
CL2024000180A1 (es) 2024-08-16
WO2019204803A1 (en) 2019-10-24
MX2020011119A (es) 2021-01-29
AU2019255402A1 (en) 2020-11-12
CN112470002A (zh) 2021-03-09
JP7733931B2 (ja) 2025-09-04
JP2021521803A (ja) 2021-08-30
KR20210010460A (ko) 2021-01-27
AU2019255402B2 (en) 2025-08-21
BR112020021372A2 (pt) 2021-01-19
EP3781945A4 (en) 2022-04-27
EP3781945A1 (en) 2021-02-24
KR102897619B1 (ko) 2025-12-09
CL2023000509A1 (es) 2023-09-29
CA3097421A1 (en) 2019-10-24
JP2023099141A (ja) 2023-07-11

Similar Documents

Publication Publication Date Title
CL2024000180A1 (es) Composiciones y métodos para tratar la endometriosis.
BR112017007965A2 (pt) método implantado por computador para inferir a atividade de uma via de sinalização celular de tgf-b em um indivíduo; aparelho para inferir a atividade de uma via de sinalização celular de tgf-b em um indivíduo; meio de armazenamento não transitório; programa de computador; kits para medir níveis de expressão de três ou mais genes-alvo da via de sinalização celular de tgf-b em uma amostra de um indivíduo; inferir a atividade de uma via de sinalização celular de tgf-b em um indivíduo; inferir a atividade de uma via de sinalização celular de tgf-b em um indivíduo; e uso do kit
EP4368992A3 (en) Simultaneous quantification of a plurality of proteins in a user-defined region of a cross-sectioned tissue
MX392706B (es) Ensayo a base de células para detectar homodímeros anti-cd3.
MX2019011040A (es) Composiciones y metodos para potenciar la expresion genica.
MX394474B (es) Métodos de pronóstico para cáncer de vejiga sin invasión muscular y antagonistas para usarse en el tratamiento de lo mismo.
EP4368728A3 (en) Simultaneous quantification of gene expression in a user-defined region of a cross-sectioned tissue
MX2017005750A (es) Ensayos para detectar subgrupos inmunes de células t y sus métodos de uso.
EA201391523A1 (ru) Композиции и способы для переноса энергии митохондрий аутологичных герминативных клеток
UY34342A (es) ?derivados de pirrolopirimidina y purina?.
BR112017010190A2 (pt) sistema para medição de características, método de medição
BR112014000965A2 (pt) método, e aparelho
EA201891304A1 (ru) ИНГИБИТОРЫ MAT2A ДЛЯ ЛЕЧЕНИЯ MTAP-null ЗЛОКАЧЕСТВЕННЫХ ОПУХОЛЕЙ
ECSP13013092A (es) Ensayo de lisiloxidasa-homólogo 2 y métodos de uso del mismo
CY1123144T1 (el) Επαγωγη καρδιακης αναγεννησης μe microrna
SG195256A1 (en) Alkylamino bodipy dyes as selective fluorescent probes for proteins andmouse embryonic stem cells
CR20190172A (es) Methods of detecting per cell pd-l1 expression and uses thereof
BR112017010078A2 (pt) composições, dispositivos e métodos de teste de sensibilidade de ibs
BR112018006393A2 (pt) método para classificar um linfoma difuso de grande célula b (dlbcl), uma ou mais mídias de armazenamento legíveis por computador, sistema de computação adaptado e kit
AR087363A1 (es) Uso del anticuerpo i-3859 para la deteccion y diagnostico de los canceres
BR112015019567A8 (pt) inibidor de wnt, seu uso e métodos para prognosticar sensibilidade ao mesmo, e composição farmacêutica
MX2012011326A (es) Sistema y metodo para evaluacion de farmaco anticanceroso candidato.
WO2015189591A3 (en) Method and arrays for use in diagnosing early breast cancer
BR112016030008A2 (pt) método para a detecção de infecção por pegivirus humano 2 em um indivíduo, para a detecção de ácido nucleico de pegivirus humano 2 e para a detecção de pegivirus humano 2 em uma amostra, e, composição
ES2721477T3 (es) Materiales y métodos para evaluar la progresión del cáncer de próstata